Inhibitors of phosphodiesterase type 5A for reducing skeletal muscle fatigue, edema, and damage in a patient having muscle fatigue due to increased age or exercise
Kevin P. Campbell,Yvonne M. Kobayashi,Robert W. Crawford
申请号：
US15163937
公开号：
US09943518B2
申请日:
2016.05.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed are pharmaceutical compositions and methods for treating or preventing muscle diseases or the symptoms thereof. The compositions typically include and the methods typically utilize phosphodiesterase type 5A inhibitors.
